| __timestamp | Bio-Techne Corporation | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 7459000 |
| Thursday, January 1, 2015 | 40853000 | 11831000 |
| Friday, January 1, 2016 | 45187000 | 25705000 |
| Sunday, January 1, 2017 | 53514000 | 46181000 |
| Monday, January 1, 2018 | 55329000 | 59497000 |
| Tuesday, January 1, 2019 | 62413000 | 65003000 |
| Wednesday, January 1, 2020 | 65192000 | 74506000 |
| Friday, January 1, 2021 | 70603000 | 126006000 |
| Saturday, January 1, 2022 | 87140000 | 126215000 |
| Sunday, January 1, 2023 | 92493000 | 120161000 |
| Monday, January 1, 2024 | 96664000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Bio-Techne Corporation and Protagonist Therapeutics, Inc. have demonstrated significant growth in their R&D investments. Bio-Techne's R&D expenses have more than tripled since 2014, reflecting a robust annual growth rate. Meanwhile, Protagonist Therapeutics has shown an even more dramatic increase, with R&D spending surging by over 1,500% from 2014 to 2023.
By 2023, Protagonist Therapeutics' R&D expenses reached a peak, surpassing Bio-Techne's by approximately 30%. This trend underscores the competitive nature of the biotech industry, where innovation is paramount. However, data for 2024 is incomplete, highlighting the dynamic and unpredictable nature of R&D investments. As these companies continue to push the boundaries of biotechnology, their R&D spending will remain a critical factor in their success.
AbbVie Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Novartis AG and Bio-Techne Corporation
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Insmed Incorporated and Protagonist Therapeutics, Inc.
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Research and Development Investment: Bio-Techne Corporation vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Perrigo Company plc
Analyzing R&D Budgets: Bio-Techne Corporation vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Alkermes plc and Protagonist Therapeutics, Inc.
R&D Insights: How Protagonist Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds
Protagonist Therapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?